Connor, Clark & Lunn Investment Management (CC&L)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-126,550
| Closed | -$2.35M | – | 1616 |
|
|
2023
Q3 | $2.35M | Sell |
126,550
-26,350
| -17% | -$489K | 0.01% | 572 |
|
|
2023
Q2 | $1.69M | Buy |
152,900
+7,609
| +5% | +$84.2K | 0.01% | 650 |
|
|
2023
Q1 | $1.95M | Buy |
145,291
+3,068
| +2% | +$41.2K | 0.01% | 558 |
|
|
2022
Q4 | $1.76M | Buy |
142,223
+6,030
| +4% | +$74.6K | 0.01% | 573 |
|
|
2022
Q3 | $1.9M | Buy |
136,193
+38,157
| +39% | +$532K | 0.01% | 507 |
|
|
2022
Q2 | $1.35M | Sell |
98,036
-8,807
| -8% | -$122K | 0.01% | 552 |
|
|
2022
Q1 | $1.74M | Sell |
106,843
-10,786
| -9% | -$175K | 0.01% | 529 |
|
|
2021
Q4 | $1.92M | Sell |
117,629
-466
| -0.4% | -$7.59K | 0.01% | 543 |
|
|
2021
Q3 | $1.75M | Sell |
118,095
-1,901
| -2% | -$28.2K | 0.01% | 546 |
|
|
2021
Q2 | $2.4M | Buy |
119,996
+8,951
| +8% | +$179K | 0.01% | 502 |
|
|
2021
Q1 | $2.56M | Buy |
+111,045
| New | +$2.56M | 0.01% | 500 |
|
|
2015
Q1 | – | Sell |
-4,300
| Closed | -$671K | – | 627 |
|
|
2014
Q4 | $671K | Buy |
+4,300
| New | +$671K | 0.01% | 352 |
|